Objective: To report the indications and outcomes of surgical treatment for hepatocellular carcinoma (HCC) in a series of operated patients. Patients and Methods: This was a retrospective descriptive study conducted from January 2022 to September 2023 in the General Surgery departments of Aristide Le Dantec hospital and Military Ouakam hospital. All patients who underwent hepatectomy for HCC were included. Patients who underwent tumorectomy were excluded. Diagnostic and therapeutic aspects were analyzed. Results: Thirteen out of 61 patients were included, with a sex ratio of 1.6 and a mean age of 38.7 years. Computed tomography (CT) demonstrated a wash-in and wash-out enhancement pattern in 9 cases, with a mean tumor size of 111.6 ± 36.5 mm. MRI revealed lesions evoking HCC in 4 of 7 cases. The mean AFP level was 788.9 ng/mL. Eleven patients were classified as BCLC stage A. Exploration through a Makuuchi incision (n = 11) revealed a micronodular liver in 4 cases. Eight major hepatectomies were performed, including 5 right hepatectomies. Intermittent total vascular clamping was used in 10 cases. Four morbidity events were recorded, including three biliary fistulas and one ischemic stroke. Three deaths and one recurrence were noted. Causes of death were liver failure (n = 2) and hemorrhagic shock (n = 1). Conclusion: In our setting, HCC predominantly affects middle-aged adults with a male predominance, and hepatitis B virus infection is the leading risk factor. Hepatic resection remains the cornerstone of curative treatment in our context.
References
[1]
Bray, F., Ferlay, J., Laversanne, M., Brewster, D.H., Gombe Mbalawa, C., Kohler, B., et al. (2015) Cancer Incidence in Five Continents: Inclusion Criteria, Highlights from Volume X and the Global Status of Cancer Registration. International Journal of Cancer, 137, 2060-2071. https://doi.org/10.1002/ijc.29670
[2]
Wu, C., Hsu, Y., Ho, H.J., Chen, Y., Lee, T. and Lin, J. (2016) Association between Ultrasonography Screening and Mortality in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study. Gut, 65, 693-701. https://doi.org/10.1136/gutjnl-2014-308786
[3]
El–Serag, H.B. and Rudolph, K.L. (2007) Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology, 132, 2557-2576. https://doi.org/10.1053/j.gastro.2007.04.061
[4]
El-Serag, H.B., Marrero, J.A., Rudolph, L. and Reddy, K.R. (2008) Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterology, 134, 1752-1763. https://doi.org/10.1053/j.gastro.2008.02.090
[5]
European Association for Study of Liver and European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. European Journal of Cancer, 48, 599-641.
[6]
Diallo, S., Bassène, M.L., Gueye, M.N., Thioubou, M.A., Dia, D., Mbengue, M., et al. (2018) Hépatite virale b: Aspects cliniques, paracliniques et évolutifs dans le service d’hépato gastroentérologie de l’hôpital aristide Le dantec: À propos de 728 cas. Pan African Medical Journal, 31, Article 82. https://doi.org/10.11604/pamj.2018.31.82.14725
[7]
Diallo, I., Ndiaye, B., Touré, M., Sow, A., Mbengue, A., Diawara, P.S., et al. (2021) Hepatocellular Carcinoma in Senegal: Epidemiological, Clinical and Etiological Aspects about 229 Cases at Hopital Principal de Dakar. Pan African Medical Journal, 38, Article 99. https://doi.org/10.11604/pamj.2021.38.99.25195
[8]
Umoh, N.J., Lesi, O.A., Mendy, M., Bah, E., Akano, A., Whittle, H., et al. (2011) Aetiological Differences in Demographical, Clinical and Pathological Characteristics of Hepatocellular Carcinoma in the Gambia. Liver International, 31, 215-221. https://doi.org/10.1111/j.1478-3231.2010.02418.x
[9]
Schütte, K., Kipper, M., Kahl, S., Bornschein, J., Götze, T., Adolf, D., et al. (2013) Clinical Characteristics and Time Trends in Etiology of Hepatocellular Cancer in Germany. Digestion, 87, 147-159. https://doi.org/10.1159/000346743
[10]
Tasu, J. and Vialle, R. (2011) Diagnostic du carcinome hépatocellulaire: Apport de l’imagerie. EMC-Hépatologie, 26, 1-11. https://doi.org/10.1016/s1155-1976(11)49333-5
[11]
Blanc, J.F., Debaillon-Vesque, A., Roth, G., Barbare, J.C., Baumann, A.S., Boige, V., et al. (2021) Hepatocellular Carcinoma: French Intergroup Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, Sfr/Fri). Clinics and Research in Hepatology and Gastroenterology, 45, Article 101590. https://doi.org/10.1016/j.clinre.2020.101590
[12]
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., et al. (2006) Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME. The American Journal of Gastroenterology, 101, 513-523. https://doi.org/10.1111/j.1572-0241.2006.00467.x
[13]
Yang, J.D., Mohamed, E.A., Aziz, A.O.A., Shousha, H.I., Hashem, M.B., Nabeel, M.M., et al. (2017) Characteristics, Management, and Outcomes of Patients with Hepatocellular Carcinoma in Africa: A Multicountry Observational Study from the Africa Liver Cancer Consortium. The Lancet Gastroenterology & Hepatology, 2, 103-111. https://doi.org/10.1016/s2468-1253(16)30161-3
[14]
Park, J., Chen, M., Colombo, M., Roberts, L.R., Schwartz, M., Chen, P., et al. (2015) Global Patterns of Hepatocellular Carcinoma Management from Diagnosis to Death: The Bridge Study. Liver International, 35, 2155-2166. https://doi.org/10.1111/liv.12818
[15]
Castaing, D. and Veilhan, L. (2008) Anatomie du foie et des voies biliaires. EMC-Hépatologie, 23, 1-14. https://doi.org/10.1016/s1155-1976(08)46207-1
